Library
PubMed
research article
Professional

Sub-voxel Susceptibility Mapping and Machine Learning to Detect Brain Iron Deposition and Its Cognitive Relevance in Beta-Thalassemia.

Source: PubMed, NCBI / U.S. National Library of Medicine

AJNR. American journal of neuroradiologyYang Mingrui, Huang Yugui, Zhu Chunxia, et al.Published 6/11/2026Last synced 6/18/2026Status: syncedPMID: 42276757DOI: 10.3174/ajnr.A9469

Brain iron dysregulation is increasingly recognized as a critical contributor to neurocognitive impairment in patients with beta-thalassemia major (&#x3b2;-TM). However, in-vivo characterization of region-specific iron accumulation and its relationship with cognitive function remains limited. Fifty &#x3b2;-TM patients and fifty age- and sex-matched healthy controls underwent 3T multi-echo gradient-echo MRI. Sub-voxel chi-separation decomposed magnetic susceptibility into paramagnetic (iron-related) and diamagnetic components. Regional paramagnetic susceptibility was extracted from anatomically defined regions of interest (ROIs). Group differences were assessed using FDR-corrected comparisons (< 0.05). Partial Spearman correlations evaluated associations between regional susceptibility and Montreal Cognitive Assessment (MoCA) scores, controlling for age, sex, and education. Three classifiers-support vector machine (SVM), random forest (RF), and eXtreme Gradient Boosting (XGBoost)-were trained using ROI-based features. In each Monte Carlo cross-validation iteration, the data were divided into stratified 80/20 training/testing subsets. Preprocessing, feature selection, and hyperparameter optimization were performed using the training data only, and the held-out test subset was used exclusively for final evaluation. SHapley Additive exPlanations (SHAP) were used for model interpretability. &#x3b2;-TM patients showed significantly higher paramagnetic susceptibility in the hippocam

Abstract

Brain iron dysregulation is increasingly recognized as a critical contributor to neurocognitive impairment in patients with beta-thalassemia major (&#x3b2;-TM). However, in-vivo characterization of region-specific iron accumulation and its relationship with cognitive function remains limited. Fifty &#x3b2;-TM patients and fifty age- and sex-matched healthy controls underwent 3T multi-echo gradient-echo MRI. Sub-voxel chi-separation decomposed magnetic susceptibility into paramagnetic (iron-related) and diamagnetic components. Regional paramagnetic susceptibility was extracted from anatomically defined regions of interest (ROIs). Group differences were assessed using FDR-corrected comparisons (< 0.05). Partial Spearman correlations evaluated associations between regional susceptibility and Montreal Cognitive Assessment (MoCA) scores, controlling for age, sex, and education. Three classifiers-support vector machine (SVM), random forest (RF), and eXtreme Gradient Boosting (XGBoost)-were trained using ROI-based features. In each Monte Carlo cross-validation iteration, the data were divided into stratified 80/20 training/testing subsets. Preprocessing, feature selection, and hyperparameter optimization were performed using the training data only, and the held-out test subset was used exclusively for final evaluation. SHapley Additive exPlanations (SHAP) were used for model interpretability. &#x3b2;-TM patients showed significantly higher paramagnetic susceptibility in the hippocampus, insula, and anterior cingulate cortex (< 0.05). Among classifiers, SVM with an RBF kernel demonstrated the highest performance (mean AUC = 0.919 &#xb1; 0.054), outperforming RF and XGBoost. SHAP analysis identified hippocampal and insular susceptibility as key features, with higher susceptibility linked to lower MoCA scores. ROI-based chi-separation detected iron-related changes in &#x3b2;-TM, and exploratory machine-learning analysis highlighted regions associated with cognitive vulnerability, supporting the potential value of susceptibility-based imaging features for studying neurocognitive risk patterns in this population.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.